Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation

Area of Science:

• Biochemistry
• Hematology
• Pharmacology

Background:

• Protamine sulfate neutralizes heparin but is paradoxically linked to increased bleeding, especially post-cardiothoracic surgery.
• The molecular mechanisms behind protamine's anticoagulant effect remain unclear.

Purpose of the Study:

• To elucidate the molecular mechanism by which protamine sulfate exerts its anticoagulant effect.
• To investigate protamine sulfate's impact on thrombin generation and factor V activation.

Main Methods:

• In vivo studies in BALB/c mice to assess thrombin generation and bleeding time.
• In vitro studies using pooled normal human plasma to evaluate prothrombin time, activated partial thromboplastin time, and thrombin generation.
• Assessed the effect of protamine sulfate on factor V activation by thrombin and factor Xa.

Main Results:

• Pharmacologic doses of protamine sulfate reduced thrombin generation and prolonged bleeding time in mice.
• Protamine sulfate caused dose-dependent prolongations in prothrombin time and activated partial thromboplastin time in human plasma.
• Protamine sulfate significantly attenuated thrombin generation and inhibited factor V activation by thrombin and factor Xa.

Conclusions:

• Protamine sulfate mediates anticoagulant activity by down-regulating thrombin generation.
• A novel mechanism involves the inhibition of factor V activation by protamine sulfate.
• Understanding this mechanism may inform strategies to mitigate bleeding risks associated with protamine sulfate administration.